Application Sponsors
ANDA 211298 | UMEDICA LABS PVT LTD | |
Marketing Status
None (Tentative Approval) | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Application Products
001 | TABLET;ORAL | 2.5MG | 0 | TADALAFIL | TADALAFIL |
002 | TABLET;ORAL | 5MG | 0 | TADALAFIL | TADALAFIL |
003 | TABLET;ORAL | 10MG | 0 | TADALAFIL | TADALAFIL |
004 | TABLET;ORAL | 20MG | 0 | TADALAFIL | TADALAFIL |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2020-07-01 | UNKNOWN |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
004 | Prescription | AB1 |
CDER Filings
UMEDICA LABS PVT LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 211298
[companyName] => UMEDICA LABS PVT LTD
[docInserts] => ["",""]
[products] => [{"drugName":"TADALAFIL","activeIngredients":"TADALAFIL","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"07\/01\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"UNKNOWN","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-07-01
)
)